01204nam0M2200397--I450 99000267907020331620190514121421.088-420-5982-X000267907USA01000267907(ALEPH)000267907USA0100026790720051027d2000----km-t0itay0103----baitaIT||||||||001yy<<L'>> impresa e la comunitaascesa e declino di un insediamento idroelettrico in CalabriaFrancesca della Ratta-RinaldiBariLaterza2000XI, 140 p.21 cmENEL cultura e industria32001ENEL cultura e industria32001001-------2001Centrali idroelettricheCalabriaBNCF338.476213DELLA RATTA-RINALDI,Francesca151624ITICCUISBD20041008990002679070203316COLL II b 3DIRCE338.476 DEL 136550 G.338.47600097441BKDIRCEECODIRCE9020051027USA011250Impresa e la comunità286924UNISA04186nam 2200937z- 450 991057688530332120220621(CKB)5720000000008321(oapen)https://directory.doabooks.org/handle/20.500.12854/84441(oapen)doab84441(EXLCZ)99572000000000832120202206d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierCoronaviruses Research in BRICS CountriesBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (168 p.)3-0365-4028-8 3-0365-4027-X SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral-host interactions. Now, with the global rollout of various COVID-19 vaccines-based on the neutralization of the spike protein using different technologies-viral immunology and cell-based immunity are being investigated. Researchers are also studying how various SARS-CoV-2 genetic mutations will impact the efficacy of these COVID-19 vaccines. At the same time, various antiviral drugs have been identified or repurposed that have potential as anti-SARS-CoV-2 treatments. BRICS (Brazil, Russia, India, China, and South Africa) is the acronym used to associate five major emerging national economies. The BRICS countries are known for their significant influence on regional affairs, including being leaders in scientific and clinical research and innovation. This Special Issue includes researchers from BRICS countries, in particular South Africa, involved in the study of SARS-CoV-2 and COVID-19. Original articles, as well as new perspectives or reviews on the matter, were welcomed. Research in the fields of vaccine studies, pathogenesis, genetic mutations, viral immunology, and antiviral drugs were especially encouraged.Epidemiology and Medical statisticsbicsscMedicine and Nursingbicsscaerosolbioinformatics and vaccine developmentBrazilbreakthroughconvalescent plasmacoronavirus disease 2019 (COVID-19)corticosteroidsCOVID-19COVID-19 and nanotechnologyCOVID-19 testingDelta and Delta plus variantdental aerosol-generating proceduresdetectiondiabetesdifferent settingsE484Kepitope coverageextra-oral suctiongenomic epidemiologyhigh-volume evacuationhospital mortalityhumoral responseimmunoassayIndiaintervention strategiesintubationlow-volume saliva ejectormodelsnanomedicine in South Africananotechnologyneutralizing antibody (NAb)NSWprotein microarrayquantitative antibody bindingreverse zoonosisSARS-CoV-2SARS-CoV-2 antibodiesSARS-CoV-2 nucleocapsid proteinsevere acute respiratory syndrome coronavirus (SARS-CoV-2)splattertreatmentvaccinevaccine development in South Africavariant of InterestVRDLwildlifeEpidemiology and Medical statisticsMedicine and NursingFielding Burtram Cedt1291013Schäfer GeorgiaedtFielding Burtram CothSchäfer GeorgiaothBOOK9910576885303321Coronaviruses Research in BRICS Countries3021755UNINA